발행물

전체 논문

41

1

α-Synuclein pathology as a target in neurodegenerative diseases.
Park, H., Kam, T. I., Dawson, V. L., Dawson, T. M.
Nature Reviews Neurology, 2024

2

Pathogenic Role of RAGE in Tau Transmission and Memory Deficits.
Kim Y, Park H, Kim Y, Kim SH, Lee JH, Yang H, Kim SJ, Li CM, Lee H, Na DH, Moon S, Shin Y, Kam TI, Lee HW, Kim S, Song JJ, Jung YK
Biological Psychiatry, 2022

3

PAAN/MIF Nuclease Inhibition Prevents Neurodegeneration in Parkinson’s Disease.
Park H*, Kam TI*, Peng H, Chou SC, Mehrabani-Tabar AA, Song JJ, Yin X, Karuppagounder SS, Umanah GK, Rao S, Choi Y, Aggarwal A, Chang S, Kim H, Byun J, Liu JO, Dawson TM, Dawson VL
Cell, 2022

4

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin.
Kam TI, Park H, Chou SC, Vranken JGV, Mittenbühler MJ, Kim H, A M, Choi YR, Biswas D, Wang J, Shin Y, Loder A, Karuppagounder SS, Wrann CD, Dawson VL, Spiegelman BM, Dawson TM
PNAS, 2022

5

Interleukin-6 triggers toxic neuronal iron sequestration in  response to pathological α-synuclein.
Sterling JK*, Kam TI*, Guttha S, Park H, Baumann B, Mehrabani-Tabari AA, Schultz H, Anderson B, Alnemri A, Chou SC, Troncoso JC, Dawson VL, Dawson TM, Dunaief J
Cell Reports, 2022

6

TRIP12 ubiquitination of glucocerebrosidase contributes to              neurodegeneration in Parkinson's disease.
Seo BA, Kim D, Hwang H, Kim MS, Ma SX, Kwon SH, Kweon SH, Wang H, Yoo JM, Choi S, Kwon SH, Kang SU, Kam TI, Kim K, Karuppagounder SS, Kang BG, Lee S, Park H, Kim S, Yan W, Li YS, Kuo SH, Redding-Ochoa J, Pletnikova O, Troncoso JC, Lee G, Mao X, Dawson VL, Dawson TM, Ko HS
Neuron, 2021

7

PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease.
Jo A*, Lee Y*, Kam TI*, Kang SU, Neifert S, Karuppagounder SS, Khang R, Kang H, Park H, Chou SC, Oh S, Jian H, Swing DA, Ham S, Pirooznia S, Umanah GKE, Mao X, Kumar M, Ko HS, Kang HC, Lee BD, Lee YI, Andrabi SA, Park CH, Lee JY, Kim H, Kim H, Kim H, Cho JW, Paek SH, Na CH, Tessarollo L, Dawson VL, Dawson TM, Shin JH
Science Translational Medicine, 2021

8

Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.
Zhang L, Chen C, Fu J, Lilley B, Berlinicke C, Hansen B, Ding D, Wang G, Wang T, Shou D, Ye Y, Mulligan T, Emmerich K, Saxena MT, Hall KR, Sharrock AV, Brandon C, Park H, Kam TI, Dawson VL, Dawson TM, Shim JS, Hanes J, Ji H, Liu JO, Qian J, Ackerley DF, Rohrer B, Zack DJ, Mumm JS
Elife, 2021

9

Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease.
Park JS*, Kam TI*, Lee S, Park H, Oh Y, Kwon SH, Song JJ, Kim D, Kim H, Jhaldiyal A, Na DH, Lee KC, Park EJ, Pomper MG, Pletnikova O, Troncoso JC, Ko HS, Dawson VL, Dawson TM, Lee S
Acta Neuropathologica Communications, 2021

10

Poly (ADP-ribose) (PAR)-dependent cell death in neuro-degenerative diseases.
Park H, Kam TI, Dawson TM, Dawson VL
International Review of Cell and Molecular Biology, 2020